Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 7, 2018; 24(1): 69-75
Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.69
Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.69
Table 1 Patient background
< 80 yr old (Group A) | ≥ 80 yr old (Group B) | P value | |
Number of patients | 184 | 88 | |
Male | 105 | 52 | NS |
Female | 79 | 36 | NS |
Pancreatic cancer | 136 | 72 | NS |
Bile duct cancer | 21 | 9 | NS |
Metastatic biliary obstruction | 13 | 3 | NS |
Papilla vater cancer | 6 | 3 | NS |
Gallbladder cancer | 6 | 1 | NS |
Intraductal papillary mucinous carcinoma | 1 | 0 | NS |
Hepatocellular carcinoma | 1 | 0 | NS |
Hepatic metastasis | 40 | 16 | NS |
Ascites | 45 | 23 | NS |
Duodenal stent indwelling | 30 | 10 | NS |
Pathological diagnosis | 161 | 89 | NS |
Performance status | |||
0 | 72 | 8 | 0.0000 |
1 | 7 | 3 | NS |
2 | 44 | 12 | 0.018 |
3 | 29 | 37 | 0.0004 |
4 | 32 | 28 | 0.0064 |
Chemotherapy | 106 | 15 | 0.0000 |
Hypertension | 55 | 52 | 0.0002 |
Hyperlipidemia | 20 | 6 | NS |
Diabetes mellitus | 50 | 31 | NS |
Chronic respiratory disease | 25 | 18 | NS |
Cardiac disease | 18 | 20 | 0.0065 |
Chronic liver disease | 18 | 6 | NS |
Chronic renal disease | 10 | 3 | NS |
Cerebrovascular disease | 5 | 20 | 0.0000 |
Dementia | 5 | 20 | 0.0000 |
Anticoagulant/antiplatelet | 9 | 23 | 0.0270 |
Table 2 Treatment effect judgment
Drainage effect | < 80 yr old (Group A; n = 184) | ≥ 80 yr old (Group B; n = 88) | P value |
Bile duct diameter prior to drainage (mm) | 11.350 ± 3.6310 (4-23) | 12.819 ± 3.3148 (5-22) | NS |
Stenosis length prior to drainage (mm) | 27.216 ± 12.688 (5-59) | 27.292 ± 12.702(6-52) | NS |
ALT prior to drainage (IU/L) | 162.767 ± 104.768 (29-851) | 127.567 ± 104.760(30-838) | NS |
ALT post drainage (IU/L) | 78.875 ± 159.482 (10-278) | 66.039 ± 143.106 (13-270) | NS |
ALP prior to drainage (IU/L) | 1529.375 ± 1465.465 (409-2620) | 1489.447 ± 1102.192 (432-2512) | NS |
ALP post drainage (IU/L) | 871.000 ± 803.131 (326-1855) | 665.622 ± 557.643 (331-1811) | NS |
T-Bil prior to drainage (mg/dl) | 5.438 ± 6.512 (0.4-27.8) | 5.276 ± 5.858 (0.6-27) | NS |
T-Bil post drainage (mg/dl) | 2.387 ± 3.879 (0.4-12.2) | 1.580 ± 3.943 (0.6-12) | NS |
Chemotherapeutic effect | |||
CR | 0 | 0 | NS |
PR | 12 | 4 | NS |
SD | 78 | 7 | 0.0000 |
PD | 16 | 4 | NS |
Total | 106 | 15 | 0.0000 |
Best supportive care | 78 | 73 | 0.0000 |
Table 3 Cause of metallic stent obstruction
Related complications | < 80 yr old(Group A; n = 184) | ≥ 80 yr old(Group B; n = 88) | P value |
Overgrowth | 10 | 7 | NS |
Ingrowth | 6 | 0 | NS |
Sludge | 16 | 10 | NS |
Stent migration | 15 | 8 | NS |
Food impaction | 3 | 4 | NS |
Others | 3 | 0 | NS |
Total | 53 | 29 | NS |
Table 4 Comparison of early procedural accidents after conducting endoscopic retrograde cholangiopancreatography
Related complications | < 80 yr old(Group A; n = 184) | ≥ 80 yr old(Group B; n = 88) | P value |
Bleeding | 0 | 0 | |
Perforation | 0 | 0 | NS |
Pancreatitis | 7 (mild) | 1 (mild) | 0.003 |
Cholangitis | 1 (mild) | 2 (mild) | NS |
Cholecystitis | 8 (6 mild, 2 moderate) | 2 (mild) | NS |
Stent migration | 1 | 0 | NS |
Pneumoniae | 0 | 2 | NS |
- Citation: Sakai Y, Iwai T, Shimura K, Gon K, Koizumi K, Ijima M, Chiba K, Nakatani S, Sugiyama H, Tsuyuguchi T, Kamisawa T, Maetani I, Kida M. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients. World J Gastroenterol 2018; 24(1): 69-75
- URL: https://www.wjgnet.com/1007-9327/full/v24/i1/69.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i1.69